The Next Big Thing In Biotech: JP Morgan Conference
Jan 04, 2013 | 5:00 AM EST - 
Adam Feuerstein, senior columnist for TheStreet, says the coming week's J.P. Morgan Healthcare Conference is the next big thing in biotech.

Columnist Conversations

That 9.09% NYC MTA increase.... not reflected in your COLA (cost of living adjustment) for Social Security, or...
EMN put in its third straight monthly high last week.
FIBOCALL: CSX CSX gap opening higher today, based on news. Our overshoot level @ 41.92 and I need to see a c...
Market is little changed as we are on the cusp of a presidential turnover.  Oil up a bit and seems to hav...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.